Topiramate is more effective than acetazolamide at lowering intracranial pressure | Zendy

William J. Scotton | Zendy; Hannah Botfield | Zendy; Connar Stanley James Westgate | Zendy; James Mitchell | Zendy; Andreas Yiangou | Zendy; Maria Uldall | Zendy; Rigmor Jensen | Zendy; Alexandra J. Sinclair | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Topiramate is more effective than acetazolamide at lowering intracranial pressure

Author(s) -

William J. Scotton,

Hannah Botfield,

Connar Stanley James Westgate,

James Mitchell,

Andreas Yiangou,

Maria Uldall,

Rigmor Jensen,

Alexandra J. Sinclair

Publication year - 2018

Publication title -

cephalalgia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.57

H-Index - 125

eISSN - 1468-2982

pISSN - 0333-1024

DOI - 10.1177/0333102418776455

Subject(s) - acetazolamide , topiramate , medicine , intracranial pressure , furosemide , pseudotumor cerebri , anesthesia , blood pressure , epilepsy , psychiatry

The management of idiopathic intracranial hypertension focuses on reducing intracranial pressure to preserve vision and reduce headaches. There is sparse evidence to support the use of some of the drugs commonly used to manage idiopathic intracranial hypertension, therefore we propose to evaluate the efficacy of these drugs at lowering intracranial pressure in healthy rats.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research